trupanion COO John Gallagher sells $12,550 in company stock

Trupanion COO John Gallagher sold 431 shares of the company's common stock, totaling $12,550, on October 28, 2026. The shares were sold at $29.12 per share, reducing his direct ownership of Trupanion common stock to 32,880 shares. Trupanion's stock has shown a 26% return over the past six months, currently trading at $30.13. Despite this recent sale, the stock appears undervalued according to InvestingPro analysis, indicating potential upside for investors.

Gallagher established a Rule 10b5-1 trading plan for this transaction on August 20, 2025. Trupanion reported stronger-than-expected Q2 2026 earnings, with earnings per share of $0.16, surpassing the forecasted $0.1133, and a 11% increase in revenue to $392.9 million. Analysts have mixed views on the company, with Piper Sandler downgrading Trupanion to Neutral from Overweight, citing macroeconomic headwinds, while acknowledging the company's strong market position and reputation among veterinarians.